Hofer, Harald

Publishing since 1993 (Senior)

Has published 48 publications in 18 years

Number of publications published per year by Hofer, Harald. (Source : PubMed)

Distribution of publications types for Hofer, Harald. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Ferenci P, Laferl H, Scherzer TM, Maieron A, Hofer H, Stauber R, Gschwantler M, Brunner H, Wenisch C, Bischof M, Strasser M, Datz C, Vogel W, Löschenberger K, Steindl-Munda P. Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response.  Gastroenterology  2010;138;2  
•  Thalwitzer S, Wachter B, Robert N, Wibbelt G, Müller T, Lonzer J, Meli ML, Bay G, Hofer H, Lutz H. Seroprevalences to viral pathogens in free-ranging and captive cheetahs (Acinonyx jubatus) on Namibian Farmland.  Clin. Vaccine Immunol.  2010;17;2  
•  Wilting A, Cord A, Hearn AJ, Hesse D, Mohamed A, Traeholdt C, Cheyne SM, Sunarto S, Jayasilan MA, Ross J, Shapiro AC, Sebastian A, Dech S, Breitenmoser C, Sanderson J, Duckworth JW, Hofer H. Modelling the species distribution of flat-headed cats (Prionailurus planiceps), an endangered South-East Asian small felid.  PLoS ONE  2010;5;3  
•  Ferenci P, Scherzer TM, Kerschner H, Rutter K, Beinhardt S, Hofer H, Schöniger-Hekele M, Holzmann H, Steindl-Munda P. Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.  Gastroenterology  2008;135;5  
•  Scherzer TM, Staufer K, Novacek G, Steindl-Munda P, Schumacher S, Hofer H, Ferenci P, Vogelsang H. Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C.  Aliment. Pharmacol. Ther.  2008;28;6  
•  Scherzer TM, Reddy KR, Wrba F, Hofer H, Staufer K, Steindl-Munda P, Gangl A, Ferenci P. Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.  J. Viral Hepat.  2008;15;9  
•  Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AW. Simplified criteria for the diagnosis of autoimmune hepatitis.  Hepatology  2008;48;1  
•  Scherzer TM, Staufer K, Novacek G, Steindl-Munda P, Schumacher S, Hofer H, Ferenci P, Vogelsang H. Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C.  Aliment. Pharmacol. Ther.  2008  
•  Ferenci P, Brunner H, Laferl H, Scherzer TM, Maieron A, Strasser M, Fischer G, Hofer H, Bischof M, Stauber R, Gschwantler M, Steindl-Munda P, Staufer K, Löschenberger K. A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.  Hepatology  2008;47;6  
•  Höfer H. [Human images in nursing--6: The person--the nurse: connection is a life source]  Pflege Z  2007;60;9  

[ See timeline ] [ See all publications ]